Kapil Dhingra 

Biography

Kapil Dhingra became a member of our board of directors in March 2014. Dr. Dhingra founded and is the head of KAPital Consulting, a healthcare consulting firm. Dr. Dhingra also serves on several emerging life science company boards, including Exosome Diagnostics Inc., and Epitherapeutics ApS. He also recently joined the board of Nasdaq listed Five Prime Therapeutics, Inc. He previously served on the Boards of several successful companies, including Biovex, Micromet, Algeta, and, YM Biosciences, that were acquired by major pharmaceutical companies. Prior to joining AAA, Dr. Dhingra worked for over 25 years in oncology clinical research and drug development. His experience includes nine years at Hoffman-La Roche, where he served in various positions, including Vice President, Head of the Oncology Disease Biology Leadership Team and Head of Oncology Clinical Development. Prior to that, he worked as a Senior Clinical Research Physician at Eli Lilly and Company. Dr. Dhingra specialized in internal medicine and medical oncology. He holds an MD (MBBS) degree from the All India Institute of Medical Sciences in New Delhi, India, with subsequent residency in internal medicine at Lincoln Medical and Mental Health Center in New York City, New York and New York Medical College in Valhalla, New York, and was a Fellow in hematology/oncology at Emory University School of Medicine in Atlanta, Georgia.

Research Interest

Bioinformatics and system biology